[Effects of diucifon on immunological indicators and dynamics of the cutaneous process in eczema patients].
D000328:Adult; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004485:Eczema / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000276:immunology*; D012397:Rosette Formation; D012867:Skin / Q000276:immunology; D013450:Sulfones / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology*; D014498:Uracil / Q000031:analogs & derivatives* / Q000627:therapeutic use
D003879:Dermatologic Agents; D004338:Drug Combinations; D013450:Sulfones; C023367:diucifon; D014498:Uracil
Vliianie diutsifona na immunologicheskie pokazateli i dinamiku kozhnogo protsessa u bol'nykh ékzemoi.